NCT00137371已完成3 期
Efficacy and Safety of 2 Low-Dose Regimens of Conjugated Estrogen Cream Administered Vaginally in Postmenopausal Women With Atrophic Vaginitis
Wyeth is now a wholly owned subsidiary of Pfizer49 个研究点 分布在 2 个国家目标入组 480 人开始时间: 2005年8月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 480
- 试验地点
- 49
- 主要终点
- To evaluate the efficacy of 2 low dose regimens of conjugated estrogen in the treatment of atrophic vaginitis from baseline to 12 weeks.
研究概览
简要总结
This protocol is designed to study the effect and safety of 2 low-dose regimens of conjugated estrogen cream (PVC) given vaginally in postmenopausal women with atrophic vaginitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 45 Years 至 80 Years(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Generally healthy postmenopausal women with symptoms of atrophic vaginitis including vaginal dryness, vaginal itching, vaginal burning, and/or painful intercourse.
- •The subject must have a clinical diagnosis of atrophic vaginitis and an intact uterus.
排除标准
- •Women who do not have a clinical diagnosis of atrophic vaginitis.
结局指标
主要结局
To evaluate the efficacy of 2 low dose regimens of conjugated estrogen in the treatment of atrophic vaginitis from baseline to 12 weeks.
次要结局
- To evaluate change from baseline in the percentage of superficial cells, symptom relief, the effect of both regimens on endometrial stimulation and genital health.
研究者
研究点 (49)
Loading locations...
相似试验
已完成
不适用
Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause WomenCRPMenopauseNCT04424173Karadeniz Technical University45
撤回
不适用
Combined Hormonal Versus Progestin Only Contraception During LactationLactationNCT00374972Shaare Zedek Medical Center
已完成
不适用
MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal SymptomsHot FlashesVasomotor DisturbanceMenopauseNCT01418209Fred Hutchinson Cancer Center339
撤回
4 期
No Resistance After Long Term Treatment SERETIDEAsthmaNCT00456313GlaxoSmithKline
已完成
1 期
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)Retinitis PigmentosaNCT02110225Dompé Farmaceutici S.p.A50
